TransMedics TMDX Stock
TransMedics Price Chart
TransMedics TMDX Financial and Trading Overview
| TransMedics stock price | 67.67 USD |
| Previous Close | 81.76 USD |
| Open | 80.81 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 2200 |
| Day's Range | 79.54 - 81.43 USD |
| 52 Week Range | 25.43 - 90.15 USD |
| Volume | 406.2K USD |
| Avg. Volume | 617.22K USD |
| Market Cap | 2.59B USD |
| Beta (5Y Monthly) | 1.44327 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 1.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 88 USD |
TMDX Valuation Measures
| Enterprise Value | 2.53B USD |
| Trailing P/E | N/A |
| Forward P/E | 724 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 21.761969 |
| Price/Book (mrq) | 13.450431 |
| Enterprise Value/Revenue | 21.266 |
| Enterprise Value/EBITDA | -127.319 |
Trading Information
TransMedics Stock Price History
| Beta (5Y Monthly) | 1.44327 |
| 52-Week Change | 203.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 90.15 USD |
| 52 Week Low | 25.43 USD |
| 50-Day Moving Average | 75.52 USD |
| 200-Day Moving Average | 63.42 USD |
TMDX Share Statistics
| Avg. Volume (3 month) | 617.22K USD |
| Avg. Daily Volume (10-Days) | 697.8K USD |
| Shares Outstanding | 32.55M |
| Float | 31.4M |
| Short Ratio | 4.51 |
| % Held by Insiders | 3.60% |
| % Held by Institutions | 93.34% |
| Shares Short | 3.49M |
| Short % of Float | 12.40% |
| Short % of Shares Outstanding | 10.71% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -23.75% |
| Operating Margin (ttm) | -20.27% |
| Gross Margin | 68.77% |
| EBITDA Margin | -16.70% |
Management Effectiveness
| Return on Assets (ttm) | -7.34% |
| Return on Equity (ttm) | -22.41% |
Income Statement
| Revenue (ttm) | 119.13M USD |
| Revenue Per Share (ttm) | 3.89 USD |
| Quarterly Revenue Growth (yoy) | 161.69% |
| Gross Profit (ttm) | 65.27M USD |
| EBITDA | -19899000 USD |
| Net Income Avi to Common (ttm) | -28305000 USD |
| Diluted EPS (ttm) | -0.91 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 195.38M USD |
| Total Cash Per Share (mrq) | 6 USD |
| Total Debt (mrq) | 67.31M USD |
| Total Debt/Equity (mrq) | 34.94 USD |
| Current Ratio (mrq) | 9.14 |
| Book Value Per Share (mrq) | 5.921 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36072000 USD |
| Levered Free Cash Flow (ttm) | -36525752 USD |
Profile of TransMedics
| Country | United States |
| State | MA |
| City | Andover |
| Address | 200 Minuteman Road |
| ZIP | 01810 |
| Phone | 978 552 0900 |
| Website | https://www.transmedics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 212 |
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Q&A For TransMedics Stock
What is a current TMDX stock price?
TransMedics TMDX stock price today per share is 67.67 USD.
How to purchase TransMedics stock?
You can buy TMDX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TransMedics?
The stock symbol or ticker of TransMedics is TMDX.
Which industry does the TransMedics company belong to?
The TransMedics industry is Medical Devices.
How many shares does TransMedics have in circulation?
The max supply of TransMedics shares is 33.66M.
What is TransMedics Price to Earnings Ratio (PE Ratio)?
TransMedics PE Ratio is 63.24298500 now.
What was TransMedics earnings per share over the trailing 12 months (TTM)?
TransMedics EPS is 1.07 USD over the trailing 12 months.
Which sector does the TransMedics company belong to?
The TransMedics sector is Healthcare.
TransMedics TMDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2500.59 USD — |
-5.81
|
— — | 2469.29 USD — | 2585.45 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1647.83 USD — |
-5.17
|
— — | 1610.28 USD — | 1681.06 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1938.96 USD — |
-4.51
|
— — | 1891.68 USD — | 1965.66 USD — | — - | — — |
- {{ link.label }} {{link}}